Oxford Instruments refocuses on nanoanalysis

06-Oct-2005
A restructuring of Oxford Instruments Analytical has been announced to better reflect the group strategy set by the new CEO, Jonathan Flint, earlier this year. This strategy is "to be the leading provider of new generation tools and systems for the Physical Science and Bioscience sectors based on our ability to observe and manipulate matter at the smallest scale". Oxford Instruments' microanalysis business, which incorporates the INCA range of ED, WD and EBSD systems and the recently acquired HKL EBSD product range, has been renamed Oxford Instruments NanoAnalysis. David Scott, who has been the Sales Director of Oxford Instruments Analytical since 1998, has been appointed Managing Director of this new group, and says "This new structure puts us in an ideal position to refocus the business on the developing requirements of nanotechnology world-wide. Through rapid, new product development aligned to a thorough understanding of our markets, we will be able to anticipate and rapidly respond to changing customer needs. I am very excited about our future"

Other news from the department business & finance

Most read news

More news from our other portals

Recognise, understand, heal: The World of Diagnostics